.Merck beats revenues assumptions, brings up sales expectation on strong demand for best drugs like Keytruda CNBCMerck & Co. (MRK US) Defeats Profit Estimates as Keytruda Sales Surge BloombergMerck Inventory: Pharma Titan Posts Powerful Results, However Expectation Tumbles Short Entrepreneur's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats revenue as well as purchases requirements surrounded by Keytruda advantage, but delivers mixed full-year expectation MarketWatch.